查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1518813

泌尿道感染檢測市場：全球產業分析、規模、佔有率、成長、趨勢、預測，2024-2031 年

Urinary Tract Infection Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 245 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發佈了一份關於全球泌尿道感染 (UTI) 檢測市場的綜合報告。該報告全面評估了主要市場動態，包括驅動因素、趨勢、機會和課題，並提供了有關市場結構的詳細見解。

關鍵見解

  • 泌尿道感染檢測市場規模（2024 年）：6.345 億美元
  • 市場預測金額（2031 年）：9.603 億美元
  • 全球市場成長率（2024-2031 年複合年增長率）：6.1%

泌尿道感染檢測市場-研究範圍：

泌尿道感染檢測涉及多種診斷方法來檢測是否存在引起泌尿道感染的病原體，包括尿液分析、尿液培養、聚合酶鏈反應（PCR）和快速試紙檢測。該市場為醫院、診所、診斷實驗室和家庭醫療保健機構提供服務，並提供各種測試類型，包括即時檢測試劑盒和基於實驗室的檢測。尿路結石盛行率的增加、早期診斷意識的提高以及提高測試準確性和改善患者治療效果的診斷技術的進步推動了市場成長。

推動市場成長的因素：

全球尿路感染檢測市場是由幾個關鍵因素推動的，例如尿路感染盛行率不斷上升，特別是在女性、老年人和慢性病患者中。人們對尿路結石早期診斷和治療重要性的認識不斷提高，進一步推動了市場的擴張。快速、靈敏的診斷測試等技術進步正在提高準確性並更快獲得結果，從而推動市場成長。此外，現場檢測的日益普及和家庭診斷服務的擴展正在為市場參與者接觸更多患者群體創造新的途徑。

市場限制因素：

儘管成長前景廣闊，但泌尿道感染檢測市場面臨監管合規性、報銷政策和先進診斷檢測的高成本等課題。有關診斷設備的製造、銷售和使用的嚴格法規給製造商和醫療保健提供者帶來了合規負擔，影響了市場進入障礙和營運成本。此外，尿石診斷檢測的報銷範圍有限以及先進檢測設備的高成本對市場滲透構成了課題，特別是在醫療預算有限的新興國家。為了解決這些監管和經濟障礙，行業利益相關者和政策制定者必須共同努力，以促進獲得負擔得起且可靠的 UTI 測試解決方案。

市場機會：

由於技術創新、人口趨勢和不斷發展的醫療服務模式，尿路感染檢測市場呈現出巨大的成長機會。遠端監控和遠距醫療平台等數位健康技術的整合增加了患者獲得診斷服務的機會，並提高了治療依從性和結果。此外，分子診斷應用的擴展以及同時檢測多種病原體的多重檢測的開發將擴大市場範圍並刺激創新。策略合作夥伴關係、研發投資以及推出用戶友好且具有成本效益的診斷解決方案對於利用新機會並保持在動態 UTI 檢測市場的領先地位至關重要。

本報告解決的關鍵問題

  • 推動全球尿路感染檢測市場成長的關鍵因素是什麼？
  • 哪些測試類型和應用程式正在推動不同醫療機構中 UTI 測試的採用？
  • 技術進步如何改變 UTI 偵測市場的競爭格局？
  • 誰是泌尿道感染檢測市場的主要參與者？ 他們保持市場地位的策略是什麼？
  • 全球尿路感染檢測市場有何新趨勢與未來前景？

目錄

第 1 章執行摘要

第二章市場概述

  • 市場範圍與定義
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 作業
    • 主要趨勢
  • 檢定生命週期分析
  • 全球尿路感染檢測市場：價值鏈
    • 測試套件供應商列表
    • 製造商列表
    • 銷售代理商名單
    • 使用列表
    • 獲利能力分析
  • 波特五力分析
  • 地緣政治緊張局勢：對市場的影響
  • 宏觀經濟因素
    • 世界產業展望
    • 全球 GDP 成長前景
    • 全球母公司市場概覽
  • 預測因子 - 相關性和影響
  • 法規與檢測試劑盒情況

第三章全球泌尿道感染檢測市場展望：實際結果（2019-2023年）與預測（2024-2031年）

  • 主要亮點
    • 市場容量（單位）預測
    • 市場規模及年成長率
    • 絕對數量的機會
  • 市場規模（百萬美元）分析與預測
    • 過去的市場規模分析，2019-2023 年
    • 目前市場規模預測（2024-2031 年）
  • 全球尿路感染檢測市場前景：檢測
    • 簡介/主要發現
    • 2019-2023 年歷史市場規模（百萬美元）和交易量（單位）的測試分析
    • 透過測試預測 2024-2031 年當前市場規模（百萬美元）和銷售量（單位）
  • 市場吸引力分析：檢查
  • 全球尿路感染檢測市場前景：檢測試劑盒
    • 簡介/主要發現
    • 2019-2023 年依測試套件劃分的歷史市場規模（百萬美元）和數量（單位）分析
    • 2024-2031 年依測試套件劃分的當前市場規模（百萬美元）和銷售量（單位）預測
  • 市場吸引力分析：測試套件
  • 全球泌尿道感染檢測市場前景：適應症
    • 簡介/主要發現
    • 2019-2023 年依適應症劃分的歷史市場規模（百萬美元）和交易量（單位）分析
    • 2024-2031 年依適應症劃分的當前市場規模（百萬美元）和銷售（單位）預測
  • 市場吸引力分析：指標
  • 全球尿路感染檢測市場展望：最終應用
    • 簡介/主要發現
    • 2019-2023 年依最終用途劃分的歷史市場規模（百萬美元）和數量（單位）分析
    • 2024-2031 年依最終用途劃分的當前市場規模（百萬美元）和銷售（單位）預測
  • 市場吸引力分析：最終用途

第 4 章全球尿路感染檢測市場展望：地區

  • 主要亮點
  • 2019-2023 年依地區歷史市場規模（百萬美元）及銷售量（單位）分析
  • 2024-2031 年依地區劃分的當前市場規模（百萬美元）和銷售（單位）預測
    • 北美
    • 歐洲
    • 東亞
    • 南亞/大洋洲
    • 拉丁美洲
    • 中東和非洲 (MEA)
  • 市場吸引力分析：地區

第五章北美泌尿道感染檢測市場展望：實際結果（2019-2023）與預測（2024-2031）

第六章歐洲泌尿道感染檢測市場前景：實際結果（2019-2023）與預測（2024-2031）

第七章東亞泌尿道感染檢測市場展望：實際（2019-2023）與預測（2024-2031）

第8章南亞/大洋洲泌尿道感染檢測市場前景：實際結果（2019-2023年）與預測（2024-2031年）

第 9 章拉丁美洲泌尿道感染檢測市場展望：實際（2019-2023 年）與預測（2024-2031 年）

第10章中東和非洲泌尿道感染檢測市場展望：實際（2019-2023年）和預測（2024-2031年）

第十一章競爭態勢

  • 2024 年市佔率分析
  • 市場結構
    • 競爭強度圖：依市場劃分
    • 競爭對手儀表板
    • 外觀檢驗能力
  • 公司簡介（詳細資料 - 概述、財務狀況、策略、近期發展）
    • ACON Laboratories Inc.
    • Cardinal Health Inc.
    • Danaher Corporation
    • SYSMEX CORPORATION
    • Abbott Laboratories
    • Bio-Rad Laboratories
    • Roche AG
    • LabCorp（Laboratory Corporation of America Holdings）.
    • Stryker Corporation
    • Thermo Fisher Scientific, Inc.

第12章附錄

  • 調查方法
  • 調查的先決條件
  • 首字母縮寫詞和縮寫詞
簡介目錄
Product Code: PMRREP33921

Persistence Market Research has recently released a comprehensive report on the worldwide market for urinary tract infection (UTI) testing. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • UTI Testing Market Size (2024E): USD 634.5 Mn
  • Projected Market Value (2031F): USD 960.3 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 6.1%

UTI Testing Market - Report Scope:

Urinary tract infection testing encompasses a variety of diagnostic methods, including urinalysis, urine culture, polymerase chain reaction (PCR), and rapid dipstick tests, to detect the presence of pathogens causing UTIs. The market caters to hospitals, clinics, diagnostic laboratories, and homecare settings, offering a range of test types, including point-of-care testing kits and laboratory-based assays. Market growth is driven by the increasing prevalence of UTIs, rising awareness about early diagnosis, and advancements in diagnostic technologies, enhancing test accuracy and patient outcomes.

Market Growth Drivers:

The global UTI testing market is propelled by several key factors, including the growing incidence of urinary tract infections, particularly among women, the elderly, and individuals with chronic conditions. Rising awareness about the importance of early diagnosis and treatment of UTIs further drives market expansion. Technological advancements, such as the development of rapid and highly sensitive diagnostic tests, offer improved accuracy and quicker results, fostering market growth. Moreover, the increasing adoption of point-of-care testing and the expansion of home-based diagnostic services create new avenues for market players to reach a wider patient population.

Market Restraints:

Despite promising growth prospects, the UTI testing market faces challenges related to regulatory compliance, reimbursement policies, and the high cost of advanced diagnostic tests. Stringent regulations governing the manufacturing, marketing, and use of diagnostic devices impose compliance burdens on manufacturers and healthcare providers, affecting market entry barriers and operational costs. Furthermore, limited reimbursement coverage for UTI diagnostic tests and the high cost of advanced testing equipment pose challenges for market penetration, particularly in emerging economies with constrained healthcare budgets. Addressing these regulatory and economic barriers requires collaboration between industry stakeholders and policymakers to promote access to affordable and reliable UTI testing solutions.

Market Opportunities:

The UTI testing market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The integration of digital health technologies, such as remote monitoring and telemedicine platforms, enhances patient access to diagnostic services and improves treatment adherence and outcomes. Furthermore, the expanding application of molecular diagnostics and the development of multiplex assays for simultaneous detection of multiple pathogens broaden the market scope and stimulate innovation. Strategic partnerships, investment in research and development, and the introduction of user-friendly, cost-effective diagnostic solutions are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic UTI testing landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the UTI testing market globally?
  • Which test types and applications are driving UTI testing adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the UTI testing market?
  • Who are the key players contributing to the UTI testing market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global UTI testing market?

Competitive Intelligence and Business Strategy:

Leading players in the global UTI testing market, including Siemens Healthineers, Abbott Laboratories, and Becton, Dickinson and Company (BD), focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced diagnostic solutions, including molecular tests and rapid testing kits, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, diagnostic laboratories, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving UTI testing landscape.

Key Companies Profiled:

  • ACON Laboratories Inc.
  • Cardinal Health Inc.
  • Danaher Corporation
  • SYSMEX CORPORATION
  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Roche AG
  • LabCorp (Laboratory Corporation of America Holdings).
  • Stryker Corporation
  • Thermo Fisher Scientific, Inc.

Urinary Tract Infection Testing Market Research Segmentation

By Tests:

  • Urinalysis
  • Urine Cultures
  • Susceptibility Testing

By Tests Kits:

  • Home Test Kits
  • Laboratory Test Kits

By Indication:

  • Cystitis
  • Urethritis
  • Pyelonephritis

By End User:

  • Hospitals
  • Nephropathy Clinics
  • Diagnostic Laboratories

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Urinary Tract Infection Testing Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Tests Lifecycle Analysis
  • 2.4. Global Urinary Tract Infection Testing Market: Value Chain
    • 2.4.1. List of Tests Kits Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Tests Kits Landscape

3. Global Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Mn ) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2019-2023
    • 3.2.2. Current Market Size Forecast, 2024-2031
  • 3.3. Global Urinary Tract Infection Testing Market Outlook: Tests
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Tests, 2019-2023
    • 3.3.3. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
      • 3.3.3.1. Urinalysis
      • 3.3.3.2. Urine Cultures
      • 3.3.3.3. Susceptibility Testing
  • 3.4. Market Attractiveness Analysis: Tests
  • 3.5. Global Urinary Tract Infection Testing Market Outlook: Tests Kits
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Tests Kits, 2019-2023
    • 3.5.3. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
      • 3.5.3.1. Home Test Kits
      • 3.5.3.2. Laboratory Test Kits
  • 3.6. Market Attractiveness Analysis: Tests Kits
  • 3.7. Global Urinary Tract Infection Testing Market Outlook: Indication
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Indication, 2019-2023
    • 3.7.3. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
      • 3.7.3.1. Cystitis
      • 3.7.3.2. Urethritis
      • 3.7.3.3. Pyelonephritis
  • 3.8. Market Attractiveness Analysis: Indication
  • 3.9. Global Urinary Tract Infection Testing Market Outlook: End Use
    • 3.9.1. Introduction / Key Findings
    • 3.9.2. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By End Use, 2019-2023
    • 3.9.3. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
      • 3.9.3.1. Hospitals
      • 3.9.3.2. Nephropathy Clinics
      • 3.9.3.3. Diagnostic Laboratories
      • 3.9.3.4. others
  • 3.10. Market Attractiveness Analysis: End Use

4. Global Urinary Tract Infection Testing Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Region, 2019-2023
  • 4.3. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Region, 2024-2031
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia and Oceania
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
    • 5.3.1. By Country
    • 5.3.2. By Tests
    • 5.3.3. By Tests Kits
    • 5.3.4. By Indication
    • 5.3.5. By End Use
  • 5.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
    • 5.5.1. Urinalysis
    • 5.5.2. Urine Cultures
    • 5.5.3. Susceptibility Testing
  • 5.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
    • 5.6.1. Home Test Kits
    • 5.6.2. Laboratory Test Kits
  • 5.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
    • 5.7.1. Cystitis
    • 5.7.2. Urethritis
    • 5.7.3. Pyelonephritis
  • 5.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
    • 5.8.1. Hospitals
    • 5.8.2. Nephropathy Clinics
    • 5.8.3. Diagnostic Laboratories
    • 5.8.4. others
  • 5.9. Market Attractiveness Analysis

6. Europe Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
    • 6.3.1. By Country
    • 6.3.2. By Tests
    • 6.3.3. By Tests Kits
    • 6.3.4. By Indication
    • 6.3.5. By End Use
  • 6.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkey
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
    • 6.5.1. Urinalysis
    • 6.5.2. Urine Cultures
    • 6.5.3. Susceptibility Testing
  • 6.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
    • 6.6.1. Home Test Kits
    • 6.6.2. Laboratory Test Kits
  • 6.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
    • 6.7.1. Cystitis
    • 6.7.2. Urethritis
    • 6.7.3. Pyelonephritis
  • 6.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
    • 6.8.1. Hospitals
    • 6.8.2. Nephropathy Clinics
    • 6.8.3. Diagnostic Laboratories
    • 6.8.4. others
  • 6.9. Market Attractiveness Analysis

7. East Asia Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
    • 7.3.1. By Country
    • 7.3.2. By Tests
    • 7.3.3. By Tests Kits
    • 7.3.4. By Indication
    • 7.3.5. By End Use
  • 7.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
    • 7.5.1. Urinalysis
    • 7.5.2. Urine Cultures
    • 7.5.3. Susceptibility Testing
  • 7.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
    • 7.6.1. Home Test Kits
    • 7.6.2. Laboratory Test Kits
  • 7.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
    • 7.7.1. Cystitis
    • 7.7.2. Urethritis
    • 7.7.3. Pyelonephritis
  • 7.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
    • 7.8.1. Hospitals
    • 7.8.2. Nephropathy Clinics
    • 7.8.3. Diagnostic Laboratories
    • 7.8.4. others
  • 7.9. Market Attractiveness Analysis

8. South Asia & Oceania Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
    • 8.3.1. By Country
    • 8.3.2. By Tests
    • 8.3.3. By Tests Kits
    • 8.3.4. By Indication
    • 8.3.5. By End Use
  • 8.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
    • 8.5.1. Urinalysis
    • 8.5.2. Urine Cultures
    • 8.5.3. Susceptibility Testing
  • 8.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
    • 8.6.1. Home Test Kits
    • 8.6.2. Laboratory Test Kits
  • 8.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
    • 8.7.1. Cystitis
    • 8.7.2. Urethritis
    • 8.7.3. Pyelonephritis
  • 8.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
    • 8.8.1. Hospitals
    • 8.8.2. Nephropathy Clinics
    • 8.8.3. Diagnostic Laboratories
    • 8.8.4. others
  • 8.9. Market Attractiveness Analysis

9. Latin America Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
    • 9.3.1. By Country
    • 9.3.2. By Tests
    • 9.3.3. By Tests Kits
    • 9.3.4. By Indication
    • 9.3.5. By End Use
  • 9.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
    • 9.5.1. Urinalysis
    • 9.5.2. Urine Cultures
    • 9.5.3. Susceptibility Testing
  • 9.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
    • 9.6.1. Home Test Kits
    • 9.6.2. Laboratory Test Kits
  • 9.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
    • 9.7.1. Cystitis
    • 9.7.2. Urethritis
    • 9.7.3. Pyelonephritis
  • 9.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
    • 9.8.1. Hospitals
    • 9.8.2. Nephropathy Clinics
    • 9.8.3. Diagnostic Laboratories
    • 9.8.4. others
  • 9.9. Market Attractiveness Analysis

10. Middle East & Africa Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
    • 10.3.1. By Country
    • 10.3.2. By Tests
    • 10.3.3. By Tests Kits
    • 10.3.4. By Indication
    • 10.3.5. By End Use
  • 10.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
    • 10.5.1. Urinalysis
    • 10.5.2. Urine Cultures
    • 10.5.3. Susceptibility Testing
  • 10.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
    • 10.6.1. Home Test Kits
    • 10.6.2. Laboratory Test Kits
  • 10.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
    • 10.7.1. Cystitis
    • 10.7.2. Urethritis
    • 10.7.3. Pyelonephritis
  • 10.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
    • 10.8.1. Hospitals
    • 10.8.2. Nephropathy Clinics
    • 10.8.3. Diagnostic Laboratories
    • 10.8.4. others
  • 10.9. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2024
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Dashboard
    • 11.2.3. Apparent Tests Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. ACON Laboratories Inc.
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Tests
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. Cardinal Health Inc.
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Tests
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. Danaher Corporation
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Tests
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. SYSMEX CORPORATION
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Tests
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. Abbott Laboratories
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Tests
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. Bio-Rad Laboratories
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Tests
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Roche AG
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Tests
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. LabCorp (Laboratory Corporation of America Holdings).
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Tests
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. Stryker Corporation
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Tests
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. Thermo Fisher Scientific, Inc.
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Tests
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations